Design, synthesis and identification of novel colchicine-derived immunosuppressant.

[1]  K. Ha,et al.  Colchicine-derived compound CT20126 promotes skin allograft survival by regulating the balance of Th1 and Th2 cytokine production , 2007, Experimental & Molecular Medicine.

[2]  J. O’Shea,et al.  A new modality for immunosuppression: targeting the JAK/STAT pathway , 2004, Nature Reviews Drug Discovery.

[3]  Jodi M. Smith,et al.  Current immunosuppressive agents: efficacy, side effects, and utilization. , 2003, Pediatric clinics of North America.

[4]  Chendong Yang,et al.  Contrasting Impacts of Immunosuppressive Agents (Rapamycin, FK506, Cyclosporin A, and Dexamethasone) on Bidirectional Dendritic Cell-T Cell Interaction During Antigen Presentation1 , 2002, The Journal of Immunology.

[5]  Z. Dvořák,et al.  Comparative effect of colchicine and colchiceine on cytotoxicity and CYP gene expression in primary human hepatocytes. , 2002, Toxicology in vitro : an international journal published in association with BIBRA.

[6]  A. Zajícová,et al.  Alloantigen-induced, T-cell-dependent production of nitric oxide by macrophages infiltrating skin allografts in mice , 2002, Transplant international : official journal of the European Society for Organ Transplantation.

[7]  H. Pae,et al.  Exogenous nitric oxide inhibits experimental autoimmune uveoretinitis development in Lewis rats by modulation of the Th1-dependent immune response. , 2001, Molecules and cells.

[8]  D. Kim,et al.  Regulation of cytokine production by exogenous nitric oxide in murine splenocyte and peritoneal macrophage , 2000, Archives of pharmacal research.

[9]  B. Kahan,et al.  Immunosuppressive agents in organ transplantation: past, present, and future. , 2000, Seminars in nephrology.

[10]  E. Vellenga,et al.  Nitric oxide selectively decreases interferon‐γ expression by activated human T lymphocytes via a cGMP‐independent mechanism , 1999, Immunology.

[11]  J. Gummert,et al.  Newer immunosuppressive drugs: a review. , 1999, Journal of the American Society of Nephrology : JASN.

[12]  A. Brossi,et al.  Antitumor agents--CLXXV. Anti-tubulin action of (+)-thiocolchicine prepared by partial synthesis. , 1997, Bioorganic & medicinal chemistry.

[13]  H. Kuiper,et al.  The use of the MTT test for determining the cytotoxicity of veterinary drugs in pig hepatocytes. , 1997, Toxicology in vitro : an international journal published in association with BIBRA.

[14]  P. Nickerson,et al.  The Th1/Th2 paradigm and the allograft response. , 1996, Current opinion in immunology.

[15]  H. Redl,et al.  Plasma glutathione S-transferase as an early marker of posttraumatic hepatic injury in non-human primates. , 1995, Shock.

[16]  A. Wahrenberger.  Pharmacologic immunosuppression: Cure or curse? , 1995, Critical care nursing quarterly.

[17]  T. P. Misko,et al.  Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase , 1995, The Journal of experimental medicine.

[18]  A. Vickers.  Use of human organ slices to evaluate the biotransformation and drug-induced side-effects of pharmaceuticals , 1994, Cell Biology and Toxicology.

[19]  N. Perico,et al.  Colchicine allows prolonged survival of highly reactive renal allograft in the rat. , 1993, Journal of the American Society of Nephrology : JASN.

[20]  M. Lovett,et al.  CYTOKINE GENE EXPRESSION IN REJECTING CARDIAC ALLOGRAFTS , 1992, Transplantation.

[21]  Stuart L. Schreiber,et al.  Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes , 1991, Cell.

[22]  C. Nathan,et al.  Downregulation of tumor necrosis factor receptors on macrophages and endothelial cells by microtubule depolymerizing agents , 1990, The Journal of experimental medicine.

[23]  K. Nakahara,et al.  PROLONGATION OF SKIN ALLOGRAFT SURVIVAL IN RATS BY A NOVEL IMMUNOSUPPRESSIVE AGENT, FK 506 , 1988, Transplantation.

[24]  F. Sakai,et al.  Effect of FK-506 on human mixed lymphocyte reaction in vitro. , 1987, Transplantation proceedings.

[25]  H. Lillehoj.  Effects of immunosuppression on avian coccidiosis: cyclosporin A but not hormonal bursectomy abrogates host protective immunity , 1987, Infection and immunity.

[26]  D. Speicher,et al.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A. , 1984, Science.

[27]  S. Stošić-Grujičić,et al.  Modulation of interleukin 1 production by activated macrophages: in vitro action of hydrocortisone, colchicine, and cytochalasin B. , 1982, Cellular immunology.

[28]  D. Dunn,et al.  CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERS , 1979, The Lancet.

[29]  I. Meza,et al.  THE MECHANISM OF ACTION OF COLCHICINE , 1973, The Journal of cell biology.

[30]  J. Klein,et al.  SEROLOGICALLY DEFINED AND LYMPHOCYTE-DEFINED COMPONENTS OF THE MAJOR HISTOCOMPATIBILITY COMPLEX IN THE MOUSE , 1972, The Journal of experimental medicine.

[31]  E. Taylor,et al.  PROPERTIES OF THE PROTEIN SUBUNIT OF CENTRAL-PAIR AND OUTER-DOUBLET MICROTUBULES OF SEA URCHIN FLAGELLA , 1968, The Journal of cell biology.

[32]  T. Sandmeyer.  Ueber die Ersetzung der Amidgruppe durch Chlor in den aromatischen Substanzen , 1884 .

[33]  C. Mioskowski,et al.  Simple and Efficient Conversion of Colchicine into Deacetylcolchicine , 1997 .

[34]  D. Lawrence,et al.  The inhibitory effects of N-ethylmaleimide, colchicine and cytochalasins on human T-cell functions. , 1989, International journal of immunopharmacology.

[35]  N. Suzuki,et al.  Diazotization and Sandmeyer reactions of arylamines in poly(ethylene glycol)–methylene dichloride: usefulness of PEG in synthetic reactions , 1987 .

[36]  F. Chemnitius.  Zur Darstellung des Colchicins , 1928 .